Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$606K Sell
8,162
-836
-9% -$67.6K 0.01% 524
2019
Q2
$764K Buy
8,998
+616
+7% +$49.4K 0.02% 462
2019
Q1
$721K Sell
8,382
-748
-8% -$60.9K 0.02% 462
2018
Q4
$581K Sell
9,130
-22
-0.2% -$1.43K 0.02% 479
2018
Q3
$632K Sell
9,152
-418
-4% -$28.7K 0.02% 527
2018
Q2
$641K Buy
9,570
+2,728
+40% +$187K 0.02% 457
2018
Q1
$570K Buy
6,842
+1,232
+22% +$111K 0.02% 488
2017
Q4
$531K Buy
5,610
+44
+0.8% +$4.6K 0.01% 521
2017
Q3
$650K Sell
5,566
-154
-3% -$19.5K 0.02% 423
2017
Q2
$720K Buy
5,720
+1,034
+22% +$132K 0.02% 394
2017
Q1
$626K Buy
+4,686
New +$597K 0.02% 400

Other funds holding INCY

Elkfork Partners's INCY Position: Q3 2019 in Review

Elkfork Partners reduced its Incyte (INCY) stake by 9.3% in Q3 2019, selling an estimated $67.6K and leaving 8,162 shares worth $606K. The position accounts for 0.01% of the portfolio, ranked #524.

Elkfork Partners first reported a position in INCY in Q1 2017 and has held it in 11 quarters since. The position peaked at $764K in Q2 2019. 497 funds tracked by Wall St. Rank hold INCY as of Q3 2019.

  • Elkfork Partners held 8,162 shares of Incyte worth $606K as of Q3 2019.
  • Elkfork Partners sold 836 Incyte shares in Q3 2019, an estimated $67.6K.
  • Incyte made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #524 holding.
  • Elkfork Partners first reported a position in Incyte in Q1 2017 and has held it in 11 quarters since.
  • Elkfork Partners's Incyte position peaked at $764K in Q2 2019.
  • 497 funds tracked by Wall St. Rank held Incyte as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.